LIMINAL BIOSCIENCES INC (LMNL) Stock Cash Flow
USA - NASDAQ:LMNL - CA53272L2021 - Common Stock
8.5 USD
+0.01 (+0.12%)
| TTM (2023-6-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -27.60M | -28.92M | -45.06M | -122.14M | -234.22M | |||
| Depreciation Amortization | 1.04M | 1.12M | 4.34M | 8.45M | 9.91M | |||
| Income Taxes - Deferred | N/A | 286.00K | 118.00K | 0.00 | 90.00K | |||
| Change In Working Capital | -1.56M | -42.00K | 1.42M | 1.13M | -14.50M | |||
| Interest Paid | 1.57M | 1.57M | 5.03M | 3.98M | 5.31M | |||
| Other non cash items | -8.29M | -4.27M | -60.43M | 36.64M | 139.34M | |||
| OPERATING CASH FLOW | -36.12M | -31.82M | -99.60M | -75.92M | -99.39M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -3.00K | -19.00K | -463.00K | -2.05M | -4.44M | |||
| Other Investing Activity | 4.37M | 3.84M | 171.16M | 4.35M | 40.54M | |||
| INVESTING CASH FLOW | 4.37M | 3.82M | 170.69M | 2.31M | 36.10M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -4.72M | -43.83M | -3.24M | 24.30M | 11.31M | |||
| Stock Issued/Repurchased | N/A | 0.00 | 0.00 | 40.04M | 118.79M | |||
| Other Financing Activity | -1.58M | -1.61M | -5.18M | -6.94M | -12.17M | |||
| FINANCING CASH FLOW | -6.30M | -45.45M | -8.42M | 57.41M | 117.92M | |||
| Exchange Rate Effect | 1.55M | 2.10M | 750.00K | 0.00 | -730.00K | |||
| CHANGE IN CASH | -36.49M | -71.35M | 63.42M | -16.20M | 53.90M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -36.12M | -31.82M | -99.60M | -75.92M | -99.39M | |||
| Capital Expenditure | -3.00K | -19.00K | -463.00K | -2.05M | -4.44M | |||
| FREE CASH FLOW | -36.12M | -31.84M | -100.07M | -77.97M | -103.83M | |||
All data in CAD